Electronic Journal of General Medicine

• WHO. Overweight and obesity. World Health Organization; 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (Accessed: 1 December 2021).
• Bray GA, Heisel WE, Afshin A, et al. The science of obesity management: An endocrine society scientific statement. Endocr Rev. 2018;39(2):79-132. https://doi.org/10.1210/er.2017-00253 PMid:29518206 PMCid:PMC5888222
• Liu T-T, Liu X-T, Chen Q-X, Shi Y. Lipase inhibitors for obesity: A review. Biomed Pharmacother. 2020;128:110314. https://doi.org/10.1016/j.biopha.2020.110314 PMid:32485574
• Avila C, Holloway AC, Hahn MK, et al. An overview of links between obesity and mental health. Curr Obes Rep. 2015; 4(3):303-10. https://doi.org/10.1007/s13679-015-0164-9 PMid:26627487
• NIDDK. Treatment for overweight & obesity. NIDDK; 2021. Available at: https://www.niddk.nih.gov/health-information/weight-management/adult-overweight-obesity/treatment (Accessed: 4 December 2021).
• Krentz AJ, Fujioka K, Hompesch M. Evolution of pharmacological obesity treatments: Focus on adverse side‐effect profiles. Diabetes Obes Metab. 2016;18(6):558-70. https://doi.org/10.1111/dom.12657 PMid:26936802
• Złotek U, Jakubczyk A, Rybczyńska-Tkaczyk K, Ćwiek P, Baraniak B, Lewicki S. Characteristics of new peptides GQLGEHGGAGMG, GEHGGAGMGGGQFQPV, EQGFLPGPEESGR, RLARAGLAQ, YGNPVGGVGH, and GNPVGGVGHGTTGT as inhibitors of enzymes involved in metabolic syndrome and antimicrobial potential. Molecules. 2020;25(11):2492. https://doi.org/10.3390/molecules25112492 PMid:32471271 PMCid:PMC7321301
• Ketprayoon T, Noitang S, Sangtanoo P, et al. An in vitro study of lipase inhibitory peptides obtained from de-oiled rice bran. RSC Adv. 2021;11(31):18915-29. https://doi.org/10.1039/D1RA01411K PMid:35478653 PMCid:PMC9033478
• Esfandi R, Seidu I, Willmore W, Tsopmo A. Antioxidant, pancreatic lipase, and α‐amylase inhibitory properties of oat bran hydrolyzed proteins and peptides. J Food Biochem. 2021:46(4):e13762. https://doi.org/10.1111/jfbc.13762 PMid:33997997
• Coronado-Cáceres LJ, Hernández-Ledesma B, Mojica L, et al. Cocoa (theobroma cacao L.) seed-derived peptides reduce blood pressure by interacting with the catalytic site of the angiotensin-converting enzyme. Foods. 2021;10(10):2340. https://doi.org/10.3390/foods10102340 PMid:34681387 PMCid:PMC8534856
• Siow H-L, Choi S-B, Gan C-Y. Structure–activity studies of protease activating, lipase inhibiting, bile acid binding and cholesterol-lowering effects of pre-screened cumin seed bioactive peptides. J Funct Foods. 2016;27:600-11. https://doi.org/10.1016/j.jff.2016.10.013
• Garzón AG, Cian RE, Aquino ME, Drago SR. Isolation and identification of cholesterol esterase and pancreatic lipase inhibitory peptides from brewer’s spent grain by consecutive chromatography and mass spectrometry. Food Funct. 2020;11(6):4994-5003. https://doi.org/10.1039/D0FO00880J PMid:32515459
• Wang J, Zhou M, Wu T, Fang L, Liu C, Min W. Novel anti-obesity peptide (RLLPH) derived from hazelnut (corylus heterophylla fisch) protein hydrolysates inhibits adipogenesis in 3T3-L1 adipocytes by regulating adipogenic transcription factors and adenosine monophosphate-activated protein kinase (AMPK) activation. J Biosci Bioeng. 2020;129(3):259-68. https://doi.org/10.1016/j.jbiosc.2019.09.012 PMid:31630942
• Martinez‐Villaluenga C, Rupasinghe SG, Schuler MA, de Mejia EG. Peptides from purified soybean β‐conglycinin inhibit fatty acid synthase by interaction with the thioesterase catalytic domain. FEBS J. 2010;277(6):1481-93. https://doi.org/10.1111/j.1742-4658.2010.07577.x PMid:20148945
• Jakubczyk A, Karaś M, Złotek U, Szymanowska U. Identification of potential inhibitory peptides of enzymes involved in the metabolic syndrome obtained by simulated gastrointestinal digestion of fermented bean (phaseolus vulgaris L.) seeds. Int Food Res J. 2017;100(Pt 1):489-96. https://doi.org/10.1016/j.foodres.2017.07.046 PMid:28873712
• Lee YG, Cho J-Y, Hwang EJ, Jeon T-I, Moon J-H. Glu–Phe from onion (allium cepa L.) attenuates lipogenesis in hepatocytes. Biosci Biotechnol Biochem. 2017;81(7):1409-16. https://doi.org/10.1080/09168451.2017.1303358 PMid:28345482
• Zhang Y, He S, Rui X, Simpson BK. Interactions of C. frondosa-derived inhibitory peptides against angiotensin I-converting enzyme (ACE), α-amylase and lipase. Food Chem. 2022;367:130695. https://doi.org/10.1016/j.foodchem.2021.130695 PMid:34365251
• Kim Y-M, Kim I-H, Choi J-W, Lee M-K, Nam T-J. The anti-obesity effects of a tuna peptide on 3T3-L1 adipocytes are mediated by the inhibition of the expression of lipogenic and adipogenic genes and by the activation of the Wnt/β-catenin signaling pathway. Int J Mol Med. 2015;36(2):327-34. https://doi.org/10.3892/ijmm.2015.2231 PMid:26046125 PMCid:PMC4501660
• Abdelhedi O, Khemakhem H, Nasri R, et al. Assessment of cholesterol, glycemia control and short-and long-term antihypertensive effects of smooth hound viscera peptides in high-salt and fructose diet-fed wistar rats. Mar Drugs. 2019;17(4):194. https://doi.org/10.3390/md17040194 PMid:30934709 PMCid:PMC6520678
• Wang Y-M, Pan X, He Y, Chi C-F, Wang B. Hypolipidemic activities of two pentapeptides (VIAPW and IRWWW) from miiuy croaker (miichthys miiuy) muscle on lipid accumulation in HepG2 cells through regulation of AMPK pathway. Appl Sci. 2020;10(3):817. https://doi.org/10.3390/app10030817
• Fan X, Cui Y, Zhang R, Zhang X. Purification and identification of anti-obesity peptides derived from spirulina platensis. J Funct Foods. 2018;47:350-60. https://doi.org/10.1016/j.jff.2018.05.066
• Zielińska E, Karaś M, Baraniak B, Jakubczyk A. Evaluation of ACE, α-glucosidase, and lipase inhibitory activities of peptides obtained by in vitro digestion of selected species of edible insects. Eur Food Res Technol. 2020;246(7):1361-9. https://doi.org/10.1007/s00217-020-03495-y
• Mudgil P, Baba WN, Kamal H, et al. A comparative investigation into novel cholesterol esterase and pancreatic lipase inhibitory peptides from cow and camel casein hydrolysates generated upon enzymatic hydrolysis and in-vitro digestion. Food Chem. 2022;367:130661. https://doi.org/10.1016/j.foodchem.2021.130661 PMid:34348197
• Mudgil P, Kamal H, Yuen GC, Maqsood S. Characterization and identification of novel antidiabetic and anti-obesity peptides from camel milk protein hydrolysates. Food Chem. 2018;259:46-54. https://doi.org/10.1016/j.foodchem.2018.03.082 PMid:29680061
• Baba WN, Mudgil P, Baby B, Vijayan R, Gan C-Y, Maqsood S. New insights into the cholesterol esterase-and lipase-inhibiting potential of bioactive peptides from camel whey hydrolysates: Identification, characterization, and molecular interaction. J Dairy Sci. 2021;104(7):7393-405. https://doi.org/10.3168/jds.2020-19868 PMid:33934858
• Lamiable A, Thévenet P, Rey J, Vavrusa M, Derreumaux P, Tufféry P. PEP-FOLD3: Faster de novo structure prediction for linear peptides in solution and in complex. Nucleic Acids Res. 2016;44(W1):W449-54. https://doi.org/10.1093/nar/gkw329 PMid:27131374 PMCid:PMC4987898
• van Zundert GCP, Rodrigues JPGLM, Trellet M, et al. The HADDOCK2.2 web server: User-friendly integrative modeling of biomolecular complexes. J Mol Biol. 2016;428(4):720-5. https://doi.org/10.1016/j.jmb.2015.09.014 PMid:26410586
• Kangueane P, Nilofer C. Protein-protein docking: Methods and tools. In: Protein-protein and domain-domain interactions. Berlin: Springer; 2018. p. 161-8. https://doi.org/10.1007/978-981-10-7347-2_14
• Medina-Franco JL, Méndez-Lucio O, Martinez-Mayorga K. The interplay between molecular modeling and chemoinformatics to characterize protein–ligand and protein–protein interactions landscapes for drug discovery. Adv Protein Chem Struct Biol. 2014;96:1-37. https://doi.org/10.1016/bs.apcsb.2014.06.001 PMid:25443953
• Lowe ME. Structure and function of pancreatic lipase and colipase. Annu Rev Nutr. 1997;17(1):141-58. https://doi.org/10.1146/annurev.nutr.17.1.141 PMid:9240923
• Winkler FK, D’Arcy A, Hunziker W. Structure of human pancreatic lipase. Nature. 1990;343(6260):771-4. https://doi.org/10.1038/343771a0 PMid:2106079
• Ayvazian L, Kerfelec B, Granon S, et al. The lipase C-terminal domain: A novel unusual inhibitor of pancreatic lipase activity. J Biol Chem. 2001;276(17):14014-8. https://doi.org/10.1074/jbc.M010328200 PMid:11154696
• Lowe ME. The catalytic site residues and interfacial binding of human pancreatic lipase. J Biol Chem. 1992;267(24):17069-73. https://doi.org/10.1016/S0021-9258(18)41893-5 PMid:1512245
• Lowe ME. Molecular mechanisms of rat and human pancreatic triglyceride lipases. J Nutr. 1997;127(4):549-57. https://doi.org/10.1093/jn/127.4.549 PMid:9109604
• Thayumanavan P, Nallaiyan S, Loganathan C, Sakayanathan P, Kandasamy S, Isa MA. Inhibition of glutathione and s-allyl glutathione on pancreatic lipase: Analysis through in vitro kinetics, fluorescence spectroscopy and in silico docking. Int J Biol Macromol. 2020;160:623-31. https://doi.org/10.1016/j.ijbiomac.2020.05.215 PMid:32473219
• Brockman HL. Kinetic behavior of the pancreatic lipase-colipase-lipid system. Biochimie. 2000;82(11):987-95. https://doi.org/10.1016/S0300-9084(00)01185-8 PMid:11099795
• Henderson GC. Plasma free fatty acid concentration as a modifiable risk factor for metabolic disease. Nutrients. 2021;13(8):2590. https://doi.org/10.3390/nu13082590 PMid:34444750 PMCid:PMC8402049
• Mancini MC, Halpern A. Pharmacological treatment of obesity. Arq Bras Endocrinol Metabol. 2006;50:377-89. https://doi.org/10.1590/S0004-27302006000200024 PMid:16767304
• Thomas A, Allouche M, Basyn F, Brasseur R, Kerfelec B. Role of the lid hydrophobicity pattern in pancreatic lipase activity. J Biol Chem. 2005;280(48):40074-83. https://doi.org/10.1074/jbc.M502123200 PMid:16179352
• Skoczinski P, Cangahuala MKE, Maniar D, Loos K. Enzymatic transesterification of urethane-bond containing ester. Colloid Polym Sci. 2021;299(3):561-73. https://doi.org/10.1007/s00396-020-04689-2
• Brandl M, Weiss MS, Jabs A, Sühnel J, Hilgenfeld R. CH⋯ π-interactions in proteins. J Mol Biol. 2001;307(1):357-77. https://doi.org/10.1006/jmbi.2000.4473 PMid:11243825
• Ding L, Wang L, Yu Z, et al. Importance of terminal amino acid residues to the transport of oligopeptides across the caco-2 cell monolayer. J Agric Food Chem. 2017; 65(35):7705-12. https://doi.org/10.1021/acs.jafc.7b03450 PMid:28812357
• Laughlin MJ, Chantler SE, Okita TW. N‐and c‐terminal peptide sequences are essential for enzyme assembly, allosteric, and/or catalytic properties of ADP‐glucose pyrophosphorylase. Plant J. 1998;14(2):159-68. https://doi.org/10.1046/j.1365-313X.1998.00102.x PMid:9628013
• Latip W, Raja Abd Rahman RNZ, Leow ATC, Mohd Shariff F, Kamarudin NHA, Mohamad Ali MS. The effect of N-terminal domain removal towards the biochemical and structural features of a thermotolerant lipase from an antarctic pseudomonas sp. strain AMS3. Int J Mol Sci. 2018;19(2):560. https://doi.org/10.3390/ijms19020560 PMid:29438291 PMCid:PMC5855782
• Weber DS, Warren JJ. The interaction between methionine and two aromatic amino acids is an abundant and multifunctional motif in proteins. Arch Biochem Biophys. 2019;672:108053. https://doi.org/10.1016/j.abb.2019.07.018 PMid:31351863
• Giese B, Wang M, Gao J, Stoltz M, Müller P, Graber M. Electron relay race in peptides. J Org Chem. 2009;74(10):3621-5. https://doi.org/10.1021/jo900375f PMid:19344128
• Valley CC, Cembran A, Perlmutter JD, et al. The methionine-aromatic motif plays a unique role in stabilizing protein structure. J Biol Chem. 2012;287(42):34979-91. https://doi.org/10.1074/jbc.M112.374504 PMid:22859300 PMCid:PMC3471747
• Zauhar R, Colbert C, Morgan R, Welsh W. Evidence for a strong sulfur–aromatic interaction derived from crystallographic data. Biopolymers. 2000;53(3):233-48. https://doi.org/10.1002/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.0.CO;2-4
• Ma B, Nussinov R. Trp/Met/Phe hot spots in protein-protein interactions: Potential targets in drug design. Curr Top Med Chem. 2007;7(10):999-1005. https://doi.org/10.2174/156802607780906717 PMid:17508933
• Suresh CH, Mohan N, Vijayalakshmi KP, George R, Mathew JM. Typical aromatic noncovalent interactions in proteins: A theoretical study using phenylalanine. J Comput Chem. 2009;30(9):1392-404. https://doi.org/10.1002/jcc.21162 PMid:19037862
• Betts MJ, Russell RB. Amino acid properties and consequences of substitutions. Bioinformatics Genetic. 2003;317:289. https://doi.org/10.1002/0470867302.ch14
• London N, Movshovitz-Attias D, Schueler-Furman O. The structural basis of peptide-protein binding strategies. Structure. 2010;18(2):188-99. https://doi.org/10.1016/j.str.2009.11.012 PMid:20159464
• Lu X, Hansen JC. Revisiting the structure and functions of the linker histone C-terminal tail domain. Biochem Cell Biol. 2003;81(3):173-6. https://doi.org/10.1139/o03-041 PMid:12897851
• Sun A-Q, Luo Y, Backos DS, et al. Identification of functionally relevant lysine residues that modulate human farnesoid X receptor activation. Mol Pharmacol. 2013; 83(5):1078-86. https://doi.org/10.1124/mol.113.084772 PMid:23462506 PMCid:PMC3920091
• Uhlig T, Kyprianou T, Martinelli FG, et al. The emergence of peptides in the pharmaceutical business: From exploration to exploitation. EuPA Open Proteomics. 2014;4:58-69. https://doi.org/10.1016/j.euprot.2014.05.003
• Anigboro AA, Avwioroko OJ, Akeghware O, Tonukari NJ. Anti-obesity, antioxidant and in silico evaluation of justicia carnea bioactive compounds as potential inhibitors of an enzyme linked with obesity: Insights from kinetics, semi-empirical quantum mechanics and molecular docking analysis. Biophys Chem. 2021;274:106607. https://doi.org/10.1016/j.bpc.2021.106607 PMid:33957576
• Hu B, Cui F, Yin F, Zeng X, Sun Y, Li Y. Caffeoylquinic acids competitively inhibit pancreatic lipase through binding to the catalytic triad. Int J Biol Macromol. 2015;80:529-35. https://doi.org/10.1016/j.ijbiomac.2015.07.031 PMid:26193679
• van Tilbeurgh H, Egloff M-P, Martinez C, Rugani N, Verger R, Cambillau C. Interfacial activation of the lipase–procolipase complex by mixed micelles revealed by X-ray crystallography. Nature. 1993;362(6423):814-20. https://doi.org/10.1038/362814a0 PMid:8479519
• Yang Y, Lowe ME. The open lid mediates pancreatic lipase function. J Lipid Res. 2000;41(1):48-57. https://doi.org/10.1016/S0022-2275(20)32073-3 PMid:10627501
• Secundo F, Carrea G, Tarabiono C, et al. The lid is a structural and functional determinant of lipase activity and selectivity. J Mol Cat B: Enzym. 2006;39(1-4):166-70. https://doi.org/10.1016/j.molcatb.2006.01.018

Vancouver

Chia TY, Gan CY, Shafie MH, Yap PG, Mohd Rodhi A, Ahmad A, et al. A comprehensive review on the pancreatic lipase inhibitory peptides: A future anti-obesity strategy. ELECTRON J GEN MED. 2023;20(3):em470. https://doi.org/10.29333/ejgm/12943

APA

Chia, T. Y., Gan, C.-Y., Shafie, M. H., Yap, P. G., Mohd Rodhi, A., Ahmad, A., Murugaiyah, V., Abdulla, M. H., & Johns, E. J. (2023). A comprehensive review on the pancreatic lipase inhibitory peptides: A future anti-obesity strategy. Electronic Journal of General Medicine, 20(3), em470. https://doi.org/10.29333/ejgm/12943

AMA

Chia TY, Gan CY, Shafie MH, et al. A comprehensive review on the pancreatic lipase inhibitory peptides: A future anti-obesity strategy. ELECTRON J GEN MED. 2023;20(3), em470. https://doi.org/10.29333/ejgm/12943

Chicago

Chia, Tan Yong, Chee-Yuen Gan, Muhammad Hakimin Shafie, Pei Gee Yap, Ainolsyakira Mohd Rodhi, Ashfaq Ahmad, Vikneswaran Murugaiyah, Mohammed H Abdulla, and Edward James Johns. "A comprehensive review on the pancreatic lipase inhibitory peptides: A future anti-obesity strategy". Electronic Journal of General Medicine 2023 20 no. 3 (2023): em470. https://doi.org/10.29333/ejgm/12943

Harvard

Chia, T. Y., Gan, C.-Y., Shafie, M. H., Yap, P. G., Mohd Rodhi, A., Ahmad, A., . . . Johns, E. J. (2023). A comprehensive review on the pancreatic lipase inhibitory peptides: A future anti-obesity strategy. Electronic Journal of General Medicine, 20(3), em470. https://doi.org/10.29333/ejgm/12943

MLA

Chia, Tan Yong et al. "A comprehensive review on the pancreatic lipase inhibitory peptides: A future anti-obesity strategy". Electronic Journal of General Medicine, vol. 20, no. 3, 2023, em470. https://doi.org/10.29333/ejgm/12943